BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Immunotherapy

Below is an extended Immunotherapy research listing. Click here to return to the Immunotherapy main in depth entry.

Recent Publications on Immunotherapy:

Clinical significance of B7-H1 (PD-L1) expression in human acute leukemia. 30th August, 2008
Department of Clinical Hematology, Second Hospital of Xi'an Jiaotong
Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission.
The most important problem in the therapy of patients with acute myeloid...
Direct Link
30th August, 2008
Department of Medical Oncology, Division of Hematologic Malignancies,
Aiming at a Curative Strategy for Follicular Lymphoma.
Follicular lymphoma is often managed as an incurable disease. However, a...
Direct Link
30th August, 2008
Immunotherapy Program, Cell Therapy Area, University of Navarra Hospital,
Therapeutic benefit of treatment with anti-thymocyte globulin and latent TGF-{beta}1 in the MRL/lpr lupus mouse model.
The pathogenesis of systemic lupus erythematosus is believed to involve...
Direct Link
30th August, 2008
Immunotherapy Research Department, Genzyme Corporation, 49 New York
Humoral immune responses against tumor-associated antigen OVA66 originally defined by serological analysis of recombinant cDNA expression libraries and its potentiality in cellular immunity.
Immunotherapy for cancer relies on the identification of tumor antigens...
Direct Link
30th August, 2008
Shanghai Institute of Immunology, Shanghai Jiaotong University School of
Dendritic cells stimulated with cytidine-phosphate-guanosine oligodeoxynucleotides and interferon-alpha-expressing tumor cells effectively reduce outgrowth of established tumors in vivo.
Dendritic cells (DC) are potent antigen-presenting cells that elicit...
Direct Link
30th August, 2008
Department of Gastroenterology, Showa University School of Medicine, 1-5-8
Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2+ glioma patients.
We recently cloned a variant form of erythropoietin-producing hepatocyte...
Direct Link
30th August, 2008
Cancer Vaccine Development Division, Kurume University Research Center for
Epstein-Barr virus nuclear antigen 1-specific CD4+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells.
Epstein-Barr virus (EBV) nuclear antigen (EBNA)1 is expressed in every...
Direct Link
30th August, 2008
Division of Immunology, Aichi Cancer Center Research Institute, Nagoya,
Immunotherapy: a way to improve the therapeutic outcome of photodynamic therapy?
Photodynamic therapy (PDT) is a treatment for cancer and non-cancerous...
Direct Link
30th August, 2008
Department of Molecular Microbiology and Serology, National Salmonella
Overcoming obstacles to the effective immunotherapy of human cancer.
Photodynamic therapy (PDT) is a treatment for cancer and non-cancerous...
Direct Link
30th August, 2008
Surgery Branch, National Cancer Institute, Bethesda, MD 20892.
Further study of anti-ICOS immunotherapy for rat cardiac allograft rejection.
PURPOSE: To study the effect of B7-CD28 costimulatory signal blockade by...
Direct Link
30th August, 2008
Department of Artificial Organ and Transplantation Surgery, Graduate
The Hospital for the Ruptured and Crippled: William Bradley Coley, Third Surgeon-in-Chief 1925-1933.
In January 1925, the Board of Managers of the New York Society for the...
Direct Link
30th August, 2008
Weill Medical College of Cornell University, New York, NY, USA,
Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patients. 30th August, 2008
Department of Cancer Therapy and Research, Graduate School of Medical
Practical blood dendritic cell vaccination for immunotherapy of multiple myeloma.
Therapeutic vaccination combined with new drugs may cure multiple myeloma...
Direct Link
30th August, 2008
Mater Medical Research Institute, The University of Queensland, Brisbane,
Food Allergy: Recent Advances in Pathophysiology and Treatment.
Food allergies, defined as an adverse immune response to food proteins,...
Direct Link
30th August, 2008
The Elliot and Roslyn Jaffe Food Allergy Institute, Division of Allergy
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional